All Journal Guides

Journal Guide

Journal of Immunology Impact Factor 3.4: Publishing Guide

Immune mechanisms: cells, signaling, and protective responses

3.4

Impact Factor (2024)

~40-50%

Acceptance Rate

~90-120 days median

Time to First Decision

What J. Immunol. Publishes

Journal of Immunology published by the American Association of Immunologists is the premier journal for immunology research. With JIF 3.4 and Q1 ranking in Immunology, JI emphasizes fundamental immune mechanisms and immunological responses. The journal publishes research on immune cells, signaling, antibodies, and immune protection. Critically: JI values mechanistic immune research. Phenotypic characterization without functional insight is less competitive. The journal seeks papers revealing immune mechanisms.

  • T cell biology: T cell receptors, activation, differentiation, memory
  • B cell biology: antibody production, B cell receptor, germinal centers
  • Innate immunity: pattern recognition, complement, innate lymphoid cells
  • Inflammatory responses: cytokines, chemokines, inflammatory pathways
  • Immune tolerance: regulatory T cells, tolerance mechanisms, immunosuppression
  • Infection immunity: antimicrobial responses, pathogen recognition
  • Immunization: vaccine development, antibody responses, immune memory
  • Translational immunology: clinical application of immune understanding

Editor Insight

JI publishes fundamental immunology revealing immune mechanisms. We seek mechanistically rigorous research with in vivo validation.

What J. Immunol. Editors Look For

Novel immune mechanism or immunological principle

Reveal new immune mechanism or cell function. New signaling pathway? Unexpected immune response? Novel immunological principle?

Rigorous immune cell characterization and functional validation

Characterize immune cells: phenotype, function, in vitro activity. Validate with loss and gain of function.

Mechanistic understanding of immune activation or tolerance

Explain immune mechanisms. What triggers response? What maintains tolerance? Mechanism crucial.

In vivo validation or model system demonstration

Show immune finding relevant in vivo. Animal models or clinical samples proving mechanism significance.

Application to infection, vaccination, or immune dysfunction

Connect immune finding to practical immunology: infection control, vaccine design, or disease treatment.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past J. Immunol.'s editorial review:

Immune cell characterization without functional significance

JI expects functional insight. Phenotyping cells alone insufficient. What do cells do? What mechanisms drive function?

In vitro studies without in vivo validation

Cell culture findings need in vivo confirmation. Show relevance in living system.

No mechanistic explanation of immune phenomenon

Describe mechanisms. What signaling? What receptors? What pathways? Mechanism essential.

Incomplete functional validation

Show function with loss and gain of function. Knockdown and overexpression both valuable.

No discussion of infection, vaccination, or disease relevance

Connect to practical immunology. Why does immune understanding matter?

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against J. Immunol.'s criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from J. Immunol. Authors

T cell receptor signaling and activation mechanisms highly valued

Fundamental T cell biology continues to drive immunology research.

Checkpoint biology and immunotherapy mechanisms competitive

Understanding checkpoint regulation and optimizing immunotherapy increasingly important.

Innate immune sensing and pattern recognition valued

Innate immunity mechanisms driving adaptive response increasingly prominent.

Immune tolerance and regulatory mechanisms gaining importance

Understanding tolerance and regulatory T cells increasingly important for autoimmunity and transplant.

Vaccine immunology and adjuvants trending

Understanding immune responses to vaccines and optimizing vaccine design increasingly competitive.

The J. Immunol. Submission Process

1

Manuscript preparation

Prep

5,000-8,000 words with 5-7 figures. Include immune cell characterization, functional assays, mechanistic studies, in vivo validation, disease application.

2

Submission via AAI system

Day 0

Submit at https://journals.aai.org/journal-of-immunology/. Required: manuscript emphasizing immune mechanism, figures showing characterization and function.

3

Editorial assessment

1-2 weeks

Editor assesses mechanistic novelty. Papers lacking functional insight or mechanism face lower priority. Moderate desk rejection ~25-35%.

4

Peer review

90-120 days

2-3 immunology experts assess novelty, functional rigor, mechanistic understanding, and in vivo significance. First decision 90-120 days.

5

Revision and publication

Revision: 4-8 weeks

Revisions often request additional functional or in vivo data. Publication 2-4 weeks after acceptance.

J. Immunol. by the Numbers

2024 Impact Factor5.1
5-Year Impact Factor5.3
Acceptance rate~40-50%
Desk rejection rate~25-35%
Median first decision~105 days
Open access option$3,200 USD
PublisherAmerican Association of Immunologists
Founded1916

Before you submit

J. Immunol. accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to J. Immunol.. ~30 minutes.

Article Types

Research Article

5,000-8,000 words

Immunology with mechanistic understanding

Landmark J. Immunol. Papers

Papers that defined fields and changed science:

  • T cell receptor signaling (various) - T cell activation mechanisms
  • Regulatory T cells (2000s+) - immune tolerance
  • Checkpoint immunotherapy (2010s+) - cancer immunotherapy
  • Vaccine adjuvants and responses (various) - vaccination immunity

Preparing a J. Immunol. Submission?

Get pre-submission feedback from reviewers who've published in J. Immunol. and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected
Confidential

Primary Fields

T Cell BiologyB Cell BiologyInnate ImmunityImmune ToleranceVaccinationImmunotherapy